Filing Details
- Accession Number:
- 0001181431-12-048803
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-05 17:51:03
- Reporting Period:
- 2012-09-04
- Filing Date:
- 2012-09-05
- Accepted Time:
- 2012-09-05 17:51:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1310880 | David Hung | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-09-04 | 2,500 | $109.68 | 1,061,774 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-09-04 | 4,200 | $110.41 | 1,057,574 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-09-04 | 17,779 | $111.52 | 1,039,795 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-09-04 | 521 | $112.04 | 1,039,274 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 86,060 | Indirect | By Trust |
Footnotes
- Shares sold pursuant to a 10b5-1 Plan.
- The shares were sold at prices ranging from $109.00 to $109.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $110.00 to $110.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $111.00 to $111.99. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $112.00 to $112.13. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.